¼¼°èÀÇ »ê¼Ò ¿ä¹ý ¼Ò¸ðǰ ½ÃÀå
Oxygen Therapy Consumables
»óǰÄÚµå : 1565124
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,322,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,966,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

»ê¼Ò ¿ä¹ý ¼Ò¸ðǰ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 136¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â 71¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â »ê¼Ò ¿ä¹ý ¼Ò¸ðǰ ¼¼°è ½ÃÀåÀº 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 9.8% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 136¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º¥Åõ¸® ¸¶½ºÅ©´Â CAGR 10.5%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö 42¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñ°­ ij´¼¶ó ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 11.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 19¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.0%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ »ê¼ÒÄ¡·á ¼Ò¸ðǰ ½ÃÀåÀº 2023³â 19¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 21¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 9.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 8.7%¿Í 8.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¾à 7.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è »ê¼Ò ¿ä¹ý ¼Ò¸ðǰ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

»ê¼Ò Ä¡·á ¼Ò¸ðǰÀ̶õ ¹«¾ùÀ̸ç, ¿Ö È£Èí±â °ü¸®¿¡ ÇʼöÀûÀΰ¡?

»ê¼ÒÄ¡·á ¼Ò¸ðǰÀº ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, Æó·Å, Äڷγª19 µî È£Èí±â Áúȯ ȯÀÚ¿¡°Ô »ê¼ÒÄ¡·á¸¦ ÇÒ ¶§ »ç¿ëÇÏ´Â ÀÏȸ¿ë Á¦Ç°À» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ò¸ðǰ¿¡´Â »ê¼Ò ¸¶½ºÅ©, ºñ°­ ij´¼¶ó, Æ©ºê, °¡½À±â, »ê¼Ò ³óÃà±â ¾×¼¼¼­¸®, »ê¼Ò Á¶Àý±â µîÀÌ Æ÷ÇԵ˴ϴÙ. »ê¼Ò ¿ä¹ýÀº Æó ±â´É Àå¾Ö·Î ÀÎÇØ ÃæºÐÇÑ »ê¼Ò ³óµµ¸¦ À¯ÁöÇϱ⠾î·Á¿î ȯÀÚ¿¡°Ô Áß¿äÇÑ Ä¡·á¹ýÀ̸ç, ÀÌ·¯ÇÑ Ä¡·á¿¡ »ç¿ëµÇ´Â ¼Ò¸ðǰÀº »ê¼Ò¸¦ ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î °ø±ÞÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. »ê¼Ò Ä¡·á ¼Ò¸ðǰÀº º´¿ø ȯ°æ, ÀçÅà ġ·á ȯ°æ ¹× ÀÀ±Þ »óȲ¿¡¼­ ȯÀÚÀÇ »óŸ¦ °ü¸®Çϰí Á¤»óÀûÀÎ ½Åü ±â´ÉÀ» À¯ÁöÇÏ´Â µ¥ ÇÊ¿äÇÑ »ê¼Ò °ø±ÞÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î È£Èí±â ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó »ê¼Ò Ä¡·á ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº »ê¼Ò Ä¡·á ¼Ò¸ðǰ »ê¾÷À» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº »ê¼Ò ¿ä¹ý ¼Ò¸ðǰÀÇ µðÀÚÀÎ, ±â´É ¹× Æí¾ÈÇÔÀ» °³¼±ÇÏ¿© »ê¼Ò °ø±ÞÀ»º¸´Ù È¿°úÀûÀÌ°í »ç¿ëÇϱ⠽±°Ô ¸¸µé¾ú½À´Ï´Ù. ÃֽŠºñ°­ ij´¼¶ó ¹× »ê¼Ò ¸¶½ºÅ©´Â ÀÎü °øÇÐÀûÀ¸·Î ¼³°èµÇ¾î ƯÈ÷ Àå±â »ç¿ëÀÚ¿¡°Ô ´õ ³ªÀº Âø¿ë°¨°ú Æí¾ÈÇÔÀ» Á¦°øÇÕ´Ï´Ù. Àç·á °úÇÐÀÇ Çõ½ÅÀ¸·Î »ê¼Ò °ø±Þ ÀåÄ¡ÀÇ Àå±â »ç¿ëÀ¸·Î ÀÎÇÑ ÇǺΠÀڱذú ¿åâÀ» ÁÙÀÏ ¼ö ÀÖ´Â °¡º±°í ÀúÀڱؼº ¼ÒÀç°¡ °³¹ßµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, »ê¼Ò °¡½À ½Ã½ºÅÛÀÇ ¹ßÀüÀ¸·Î ȯÀÚ¿¡°Ô Àü´ÞµÇ´Â °ø±â°¡ ÀûÀýÈ÷ °¡½ÀµÇ¾î ±âµµ °ÇÁ¶ ¹× ¿°ÁõÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀϺΠÁ¦Á¶¾÷ü´Â °¨¿°À» ¿¹¹æÇϰí ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ã۱â À§ÇØ »ê¼Ò Ä¡·á Æ©ºê¿Í ¸¶½ºÅ©¿¡ Ç×±Õ ÄÚÆÃÀ» Àû¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ê¼Ò Ä¡·á ¼Ò¸ðǰÀº ÈÞ´ë¿ë »ê¼Ò ³óÃà±â¿¡ ´ëÇÑ ÀûÀÀ¼ºÀ» ³ô¿© ÁýÀ̳ª À̵¿ Áß¿¡µµ »ê¼Ò Ä¡·á¸¦ ¹Þ´Â ȯÀÚ°¡ Æí¾ÈÇÔ°ú À̵¿¼ºÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

»ê¼Ò ¿ä¹ý ¼Ò¸ðǰÀº ¾îµð¿¡ »ç¿ëµÇ³ª¿ä?

»ê¼Ò ¿ä¹ý ¼Ò¸ðǰÀº º´¿ø, ÀçÅÃÄ¡·á ¹× ÀÀ±Þ ÀÇ·á¿¡¼­ °¡Àå ³Î¸® »ç¿ëµË´Ï´Ù. º´¿ø¿¡¼­´Â ÁßȯÀÚ½Ç, ÀÀ±Þ½Ç, ȸº¹±â¿¡ º¸Á¶ »ê¼Ò°¡ ÇÊ¿äÇÑ ¼ö¼ú ÈÄ È¯ÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¼Ò¸ðǰÀº Æó·Å ¹× Äڷγª19 ÇÕº´Áõ°ú °°ÀÌ »ê¼Ò ¿ä¹ýÀÌ ÁÖ¿ä Ä¡·á¹ýÀÎ ±Þ¼º È£Èí±â Áúȯ °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù. COPD¿Í °°Àº ¸¸¼º È£Èí±â Áúȯ ȯÀÚ°¡ »îÀÇ ÁúÀ» À¯ÁöÇϱâ À§ÇØ Àå±âÀûÀÎ »ê¼Ò ¿ä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â ÀçÅà ġ·á ȯ°æ¿¡¼­ »ê¼Ò ¿ä¹ý ¼Ò¸ðǰÀº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ºñ°­ ij´¼¶ó ¹× ¸¶½ºÅ©¿Í °°Àº ¼Ò¸ðǰ°ú °áÇÕµÈ ÈÞ´ë¿ë »ê¼Ò Ä¡·á Àåºñ´Â À̵¿¼ºÀ» À¯ÁöÇϸ鼭 »ê¼Ò ÈíÀÔÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÀ±ÞÀÇ·á¼­ºñ½º(EMS)µµ ¿Ü»óȯÀÚ, ½ÉÁ¤Áö ȯÀÚ, ±Þ¼º È£ÈíºÎÀü ȯÀÚÀÇ Áï°¢ÀûÀÎ Ä¡·á¸¦ À§ÇØ »ê¼ÒÄ¡·á ¼Ò¸ðǰÀ» Àû±Ø Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù.

»ê¼Ò Ä¡·á ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀå µ¿·ÂÀº ¹«¾ùÀΰ¡?

»ê¼Ò ¿ä¹ý ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, COPD, õ½Ä, Æó¾Ï°ú °°Àº ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Áß¿äÇÑ ÃËÁøÁ¦À̸ç, ÀÌ·¯ÇÑ Áúº´Àº Á¾Á¾ È¿°úÀûÀÎ °ü¸®°¡ ÇÊ¿äÇÕ´Ï´Ù. È¿°úÀûÀÎ °ü¸®¸¦ À§ÇØ Àå±âÀûÀÎ »ê¼Ò ¿ä¹ýÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ³ëÀÎÀº È£Èí±â Áúȯ¿¡ °É¸®±â ½±°í »ê¼Ò ¿ä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â ºóµµ°¡ ³ô±â ¶§¹®¿¡ Äڷγª19 »çÅ´ ÁßÁõ È£Èí±â °¨¿° Ä¡·á¿¡¼­ »ê¼Ò ¿ä¹ýÀÇ Á߿伺À» ºÎ°¢½ÃÄÑ º´¿ø°ú ÀçÅà °£È£ ¸ðµÎ¿¡¼­ »ê¼Ò ¿ä¹ý ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄ×½À´Ï´Ù. ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀüÀº »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ°¡ º´¿ø ¹Û¿¡¼­ ¸¸¼ºÁúȯÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â ÀçÅÃÀÇ·áÀÇ ¹ßÀüÀº ÈÞ´ë¿ë »ê¼ÒÄ¡·á±â ¹× °ü·Ã ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃŰ¸ç ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÁÖ¸ñ¹Þ´Â 44°³»ç)

  • Allied Healthcare Products, Inc.
  • Ambu A/S
  • Becton, Dickinson & Company
  • Besmed Health Business Corporation
  • BLS Systems Ltd.
  • Circadiance
  • Drive DeVilbiss Healthcare
  • Fisher & Paykel Healthcare Ltd.
  • Flexicare Medical Ltd.
  • Philips Respironics
  • Resmed Corporation
  • Smiths Medical
  • Teleflex Inc.

    ¸ñÂ÷

    Á¦1Àå Á¶»ç ¹æ¹ý

    Á¦2Àå ÁÖ¿ä ¿ä¾à

    • ½ÃÀå °³¿ä
    • ÁÖ¿ä ±â¾÷
    • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
    • ¼¼°è ½ÃÀå Àü¸Á

    Á¦3Àå ½ÃÀå ºÐ¼®

    • ¹Ì±¹
    • ij³ª´Ù
    • ÀϺ»
    • Áß±¹
    • À¯·´
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ±âŸ À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±âŸ Áö¿ª

    Á¦4Àå °æÀï

    LSH
  • ¿µ¹® ¸ñÂ÷

    ¿µ¹®¸ñÂ÷

    Global Oxygen Therapy Consumables Market to Reach US$13.6 Billion by 2030

    The global market for Oxygen Therapy Consumables estimated at US$7.1 Billion in the year 2023, is expected to reach US$13.6 Billion by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Venturi Mask, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Nasal Cannula segment is estimated at 11.0% CAGR over the analysis period.

    The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 9.0% CAGR

    The Oxygen Therapy Consumables market in the U.S. is estimated at US$1.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

    Global Oxygen Therapy Consumables Market – Key Trends & Drivers Summarized

    What Are Oxygen Therapy Consumables, and Why Are They Essential in Respiratory Care?

    Oxygen therapy consumables refer to the disposable products used in administering oxygen therapy to patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and COVID-19. These consumables include oxygen masks, nasal cannulas, tubing, humidifiers, oxygen concentrator accessories, and oxygen regulators. Oxygen therapy is a critical treatment for patients who struggle to maintain adequate oxygen levels due to lung dysfunction, and the consumables used in these therapies ensure the safe and effective delivery of oxygen. Oxygen therapy consumables are vital in hospital settings, home care environments, and emergency situations, ensuring that patients receive the necessary oxygen supply to manage their conditions and maintain normal bodily functions. With the rising incidence of respiratory diseases worldwide, the demand for oxygen therapy consumables continues to grow.

    How Are Technological Advancements Shaping the Oxygen Therapy Consumables Industry?

    Technological advancements are improving the design, functionality, and comfort of oxygen therapy consumables, making oxygen delivery more effective and user-friendly. Modern nasal cannulas and oxygen masks are being designed with more ergonomic features, providing better fit and comfort, especially for long-term users. Innovations in material science have led to the development of lightweight, hypoallergenic materials that reduce skin irritation and pressure sores associated with extended use of oxygen delivery devices. Additionally, advancements in oxygen humidification systems are ensuring that the air delivered to patients is properly moistened, reducing the risk of airway dryness and irritation. Some manufacturers are integrating antimicrobial coatings into oxygen therapy tubing and masks to prevent infections and improve patient safety. Furthermore, oxygen therapy consumables are becoming more adaptable to portable oxygen concentrators, ensuring that patients receiving oxygen therapy at home or on the go can maintain comfort and mobility.

    Where Are Oxygen Therapy Consumables Most Widely Used?

    Oxygen therapy consumables are most widely used in hospitals, homecare settings, and emergency services. In hospitals, they are used in critical care units, emergency rooms, and for post-operative patients who require supplemental oxygen during recovery. These consumables are essential in managing acute respiratory conditions, such as pneumonia or complications from COVID-19, where oxygen therapy is a primary treatment. In homecare environments, oxygen therapy consumables are crucial for patients with chronic respiratory diseases like COPD, who require long-term oxygen therapy to maintain quality of life. Portable oxygen therapy devices paired with consumables such as nasal cannulas and masks are widely used by patients who need oxygen support while maintaining mobility. Emergency medical services (EMS) also rely heavily on oxygen therapy consumables for delivering immediate care to trauma victims, cardiac arrest patients, and individuals with acute respiratory failure.

    What Is Driving the Growth of the Oxygen Therapy Consumables Market?

    The growth in the oxygen therapy consumables market is driven by several factors, including the rising prevalence of respiratory diseases, the growing elderly population, and advancements in healthcare infrastructure. The increasing incidence of chronic respiratory conditions like COPD, asthma, and lung cancer is a significant driver, as these conditions often require long-term oxygen therapy for effective management. The aging global population is another key factor, as elderly individuals are more prone to respiratory issues and require oxygen therapy more frequently. The COVID-19 pandemic highlighted the critical importance of oxygen therapy in treating severe respiratory infections, boosting demand for oxygen therapy consumables in both hospital and homecare settings. Advancements in healthcare infrastructure, particularly in emerging markets, are improving access to oxygen therapy, further driving market growth. Additionally, the trend toward home healthcare, where patients manage chronic conditions outside of hospitals, is increasing the demand for portable oxygen therapy devices and associated consumables, enhancing market expansion.

    Select Competitors (Total 44 Featured) -

    TABLE OF CONTENTS

    I. METHODOLOGY

    II. EXECUTIVE SUMMARY

    III. MARKET ANALYSIS

    IV. COMPETITION

    (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
    ¨Ï Copyright Global Information, Inc. All rights reserved.
    PC¹öÀü º¸±â